Pharma-Doctor Nexus In JK : Govt Decides To Go Tough

Srinagar: At a time when the unholy nexus between the doctors and pharma companies are putting patients at risk of even losing their life in the state, the government Monday claimed to crack the whip soon on this deep nexus.

One of the top officials in the state health department told KNS that on the directions of Chief Minister Mehbooba Mufti, the government has decided to act tough against the doctors prescribing substandard drugs for monetary benefits. “The government is receiving complaints that some doctors are involved in this activity. Even the Chief Minister’s office has received complaints in this regard. Now we have decided to go tough against the erring doctors and who so ever will be found involved will be dealt severely,” the top official informed KNS on condition of anonymity.

The official said that it has been reported that the doctors prescribe the substandard medicines to get the monetary benefits. “The government does not have any problem if the companies produce quality medicine. The production of substandard medicine by any company will not be tolerated. The doctors should also exhibit their responsibility by prescribing only the genuine medicine to the suffering patients,” the official maintained

Sources said that the government is also planning to control freebies given by pharmaceutical companies to doctors.

It is to mention here that a committee of Jammu and Kashmir Legislative Assembly had asked the state government to act “tough” against the medicos and the pharmaceutical companies responsible for selling poisonous medicines in the state.

“The Government must act tough to break the nexus between the medicos and the substandard pharmaceutical companies who are playing with the lives of the innocent people by selling poisonous medicines, Committee on Estimates had said during the review meeting of Health and Medical Education Department.

The committee had also asked the Controller, Drug and Food Control Organization, to submit a comprehensive report to the Legislative Assembly Secretariat, regarding how many samples of drugs the organization had lifted from various areas of the State for testing.

A senior doctor said that, it is a well known fact that most pharmaceutical companies are spending more money on marketing activity than their research. “Such activities by pharmaceutical or allied health sector companies definitely lead to a situation where a section of doctors prescribes, substandard , unwanted costly medicines or investigations to meet the target of diagnostic laboratories and pharma companies,” the doctor said insisted not to be named. (KNS)



Follow this link to join our WhatsApp group: Join Now

Be Part of Quality Journalism

Quality journalism takes a lot of time, money and hard work to produce and despite all the hardships we still do it. Our reporters and editors are working overtime in Kashmir and beyond to cover what you care about, break big stories, and expose injustices that can change lives. Today more people are reading Kashmir Observer than ever, but only a handful are paying while advertising revenues are falling fast.



Leave a Reply

Your email address will not be published.